Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 6Mesothelioma 2Malignant Solid Tumour 2Mesothelioma, Malignant 1Lung Neoplasms 1

Interventions

Vorinostat 2pembrolizumab 1nintedanib 1dactolisib 1avelumab 1Vinorelbine 1Sunitinib 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Hydroxychloroquine 1Folfox protocol 1Fluorouracil 1Dasatinib 1DOXO-EMCH 1Cetuximab 1Bevacizumab 1BN 80927 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Malignant Solid Tumour × Vorinostat × Other solid neoplasm × Clear all
NCT01023737 2023-02-13

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

The University of Texas Health Science Center at San Antonio

Phase 1 Completed
72 enrolled
Other solid neoplasm

Malignant Solid Tumour

NCT00801151 2010-05-20

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Institut Claudius Regaud

Phase 1 Terminated
30 enrolled
Other solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡